BACKGROUND: Substance use is a known predictor of poor adherence to antiretroviral therapies (ART) in people living with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome. Less studied is the association between substance use and treatment outcomes, namely, suppression of HIV replication. METHODS: Adults living with HIV (N = 183) who reported alcohol use in the previous week and receiving ART were observed over a 12-month period. Participants completed computer interviews, monthly unannounced pill counts to monitor ART adherence, and daily cell-phone delivered interactive-text assessments for alcohol use. HIV viral load was collected at baseline and 12-month follow-up from medical records. Analyses compared participants who had undetectable HIV viral loads at baseline and follow-up (sustained viral suppression) to those with unsustained viral suppression. Analyses also compared participants who were adherent to their medications (>85 % pills taken) over the year of observation to those who were nonadherent. RESULTS: Fifty-two percent of participants had unsustained viral suppression; 47 % were ART nonadherent. Overall results failed to demonstrate alcohol use as a correlate of sustained viral suppression or treatment adherence. However, alcohol use was associated with nonadherence among participants who did not have sustained viral suppression; nonadherence in unsustained viral suppression patients was related to drinking on fewer days of assessment, missing medications when drinking, and drinking socially. CONCLUSIONS: Poor HIV treatment outcomes and nonadherence were prevalent among adults treated for HIV infection who drink alcohol. Drinking in relation to missed medications and drinking in social settings are targets for interventions among alcohol drinkers at greatest risk for poor treatment outcomes.
BACKGROUND: Substance use is a known predictor of poor adherence to antiretroviral therapies (ART) in people living with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome. Less studied is the association between substance use and treatment outcomes, namely, suppression of HIV replication. METHODS: Adults living with HIV (N = 183) who reported alcohol use in the previous week and receiving ART were observed over a 12-month period. Participants completed computer interviews, monthly unannounced pill counts to monitor ART adherence, and daily cell-phone delivered interactive-text assessments for alcohol use. HIV viral load was collected at baseline and 12-month follow-up from medical records. Analyses compared participants who had undetectable HIV viral loads at baseline and follow-up (sustained viral suppression) to those with unsustained viral suppression. Analyses also compared participants who were adherent to their medications (>85 % pills taken) over the year of observation to those who were nonadherent. RESULTS: Fifty-two percent of participants had unsustained viral suppression; 47 % were ART nonadherent. Overall results failed to demonstrate alcohol use as a correlate of sustained viral suppression or treatment adherence. However, alcohol use was associated with nonadherence among participants who did not have sustained viral suppression; nonadherence in unsustained viral suppressionpatients was related to drinking on fewer days of assessment, missing medications when drinking, and drinking socially. CONCLUSIONS: Poor HIV treatment outcomes and nonadherence were prevalent among adults treated for HIV infection who drink alcohol. Drinking in relation to missed medications and drinking in social settings are targets for interventions among alcohol drinkers at greatest risk for poor treatment outcomes.
Authors: David R Bangsberg; Edwin D Charlebois; Robert M Grant; Mark Holodniy; Steven G Deeks; Sharon Perry; Kathleen Nugent Conroy; Richard Clark; David Guzman; Andrew Zolopa; Andrew Moss Journal: AIDS Date: 2003-09-05 Impact factor: 4.177
Authors: Karen L Cropsey; James H Willig; Michael J Mugavero; Heidi M Crane; Cheryl McCullumsmith; Sarah Lawrence; James L Raper; W Christopher Mathews; Stephen Boswell; Mari M Kitahata; Joseph E Schumacher; Michael S Saag Journal: J Addict Med Date: 2016 Jan-Feb Impact factor: 3.702
Authors: Anthony T Fojo; Catherine R Lesko; Keri L Calkins; Richard D Moore; Mary E McCaul; Heidi E Hutton; William C Mathews; Heidi Crane; Katerina Christopoulos; Karen Cropsey; Michael J Mugavero; Kenneth Mayer; Brian W Pence; Bryan Lau; Geetanjali Chander Journal: AIDS Behav Date: 2019-03
Authors: Natalie E Kelso-Chichetto; Michael Plankey; Alison G Abraham; Nicole Ennis; Xinguang Chen; Robert Bolan; Robert L Cook Journal: Am J Drug Alcohol Abuse Date: 2017-06-16 Impact factor: 3.829
Authors: David H Barker; Nicole R Nugent; Jeanne R Delgado; Valerie S Knopik; Larry K Brown; Michelle A Lally; John E McGeary Journal: AIDS Care Date: 2017-02-21
Authors: Kirsha S Gordon; E Jennifer Edelman; Amy C Justice; David A Fiellin; Kathleen Akgün; Stephen Crystal; Mona Duggal; Joseph L Goulet; David Rimland; Kendall J Bryant Journal: AIDS Behav Date: 2017-05
Authors: Ryan P Coyle; Christopher D Schneck; Mary Morrow; Stacey S Coleman; Edward M Gardner; Jia-Hua Zheng; Lucas Ellison; Lane R Bushman; Jennifer J Kiser; Samantha Mawhinney; Peter L Anderson; Jose R Castillo-Mancilla Journal: AIDS Behav Date: 2019-12
Authors: Kathryn E Lancaster; Thandie Lungu; Pearson Mmodzi; Mina C Hosseinipour; Katy Chadwick; Kimberly A Powers; Brian W Pence; Vivian F Go; Irving F Hoffman; William C Miller Journal: AIDS Care Date: 2016-07-21